Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00996047 · ClinicalTrials.gov registry record
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
A clinical trial, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 3,341
- Enrollment target
NCT00996047 is a clinical trial that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 3,341 participants.
The verdict
NCT00996047 has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 3,341 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at bone marrow and blood samples from patients with leukemia or other hematopoietic cancers.
Interventions
- GENETIC cytogenetic analysis
- GENETIC fluorescence in situ hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,341 participants |
| Start Date | 1991-07 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00996047
The ClinicalTrials.gov registry entry for NCT00996047 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,341 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cytogenetic analysis is the first listed.
NCT00996047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00996047 about?
NCT00996047 is a clinical study titled "S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers". RATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research stu...
What is the current status of trial NCT00996047?
This trial is currently completed. The enrollment target is 3,341 participants. The study started on 1991-07. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00996047?
The interventions under investigation include: cytogenetic analysis (GENETIC), fluorescence in situ hybridization (GENETIC).
Who is sponsoring clinical trial NCT00996047?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.